Glenmede Trust’s Discovery, Inc. Series B Common Stock DISCB Stock Holding History

Glenmede Trust’s Portfolio DISCB Stock Details DISCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-536	Closed	-$14K	–	1414
2022 Q1	$14K	Hold	536	–	–	﹤0.01%	1284
2021 Q4	$15K	Hold	536	–	–	﹤0.01%	1288
2021 Q3	$26K	Hold	536	–	–	﹤0.01%	1233
2021 Q2	$34K	Hold	536	–	–	﹤0.01%	1220
2021 Q1	$68K	Hold	536	–	–	﹤0.01%	1117
2020 Q4	$17K	Hold	536	–	–	﹤0.01%	1157
2020 Q3	$17K	Hold	536	–	–	﹤0.01%	1684
2020 Q2	$20K	Hold	536	–	–	﹤0.01%	1606
2020 Q1	$19K	Hold	536	–	–	﹤0.01%	2131
2019 Q4	$19K	Hold	536	–	–	﹤0.01%	2131
2019 Q3	$16	Hold	536	–	–	﹤0.01%	2160
2019 Q2	$18	Hold	536	–	–	﹤0.01%	2111
2019 Q1	$16	Buy	+536	New	+$17.8K	﹤0.01%	2185

Other funds holding DISCB

MPIM

McGinn Penninger Investment Management Alexandria, Virginia $153M AUM 20.6% 1-Year Est. Return

Glenmede Trust's DISCB Position: Q2 2022 in Review

Glenmede Trust sold out of Discovery, Inc. Series B Common Stock (DISCB) in Q2 2022, closing a stake of 536 shares — an estimated $14K sold.

Glenmede Trust first reported a position in DISCB in Q1 2019 and held it in 13 quarters. The position peaked at $68K in Q1 2021. 1 fund tracked by Wall St. Rank holds DISCB as of Q2 2022.

Glenmede Trust reported no remaining Discovery, Inc. Series B Common Stock position as of Q2 2022 after selling out during the quarter.
Glenmede Trust sold 536 Discovery, Inc. Series B Common Stock shares in Q2 2022, an estimated $14K.
Glenmede Trust first reported a position in Discovery, Inc. Series B Common Stock in Q1 2019 and held it in 13 quarters.
Glenmede Trust's Discovery, Inc. Series B Common Stock position peaked at $68K in Q1 2021.
1 fund tracked by Wall St. Rank held Discovery, Inc. Series B Common Stock as of Q2 2022.

Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.